Drugnews|藥時事

Astellas Pharma Inc.

Astellas Pharma Inc. has a source-backed asset record in this dataset as of 2026-11-01.

Country / operating region
Japan
Ticker
4503.T
Headquarters
查無
Founded
查無
Business
Biopharmaceutical research and development
Website
www.astellas.com

Pipeline / products

AssetRegistered / announced phaseTrialStatusSponsorRecord date
fezolinetant (VEOZA)Approved ex-US as VEOZA (undated pipeline note)—查無查無查無

Licensing deals

查無

Catalysts

查無

Latest monthly revenue

查無

Most advanced drug

查無

Drugnews analysis

查無